Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Kenny Galvez
Efficacy of Generic Bortezomib Used as a Part of CyBorD Regimen to Achieve Complete Response in Multiple Myeloma
Innovative Journal of Medical and Health Science
Related publications
Efficacy and Safety of Reduced-Intensity Induction Therapy With a Bortezomib-Based Regimen in Elderly Patients With Multiple Myeloma
Therapeutic Advances in Hematology
Hematology
Attainment of a Stringent Complete Response in Multiple Myeloma With Thalidomide Monotherapy
Internal Medicine
Internal Medicine
Medicine
Bortezomib for the Treatment of Multiple Myeloma Patients
Health Technology Assessment
Medicine
Health Policy
Intravenous (IV) Bortezomib Infusion After Non-Response to Subcutaneous Bortezomib Administration Can Induce Transitory Responses in Multiple Myeloma Patients: Are Some Patients More Sensitive to IV Bortezomib?
British Journal of Haematology
Hematology
Efficacy of Subcutaneous Bortezomib in the Management of Patients With Multiple Myeloma or Relapsed Mantle Cell Lymphoma
Clinical Medicine Insights: Therapeutics
Medicine
Pharmacology
Pharmaceutical Science
Bortezomib: The Evidence of Its Clinical Impact in Multiple Myeloma
Core Evidence
Medicine
Reviews
References
Pharmacology
Intracellular Glutathione Determines Bortezomib Cytotoxicity in Multiple Myeloma Cells
Blood Cancer Journal
Oncology
Hematology
Bortezomib Induces Heme Oxygenase-1 Expression in Multiple Myeloma
Cell Cycle
Medicine
Developmental Biology
Cell Biology
Molecular Biology
Blood Distribution of Bortezomib and Its Kinetics in Multiple Myeloma Patients
Clinical Biochemistry
Medicine
Clinical Biochemistry
